DIGITAL DIABETES MANAGEMENT MARKET ANALYSIS
Global Digital Diabetes Management Market: Key Developments
In November 2022, Eli Lilly and Company (LLY) planned to rollout first connected platform, the Tempo Personalized Diabetes Management Platform, in the U.S. The platform aims to help people living with Type 1 and Type 2 diabetes and clinicians make informed, data-backed decisions to manage treatment with Lilly insulins.
In April 2022, Dexcom announced the launch of new Dexcom One continuous glucose monitoring (CGM) system in the U.K. The Dexcom One system as an easy-to-use, real-time CGM that it aims to make more affordable and accessible for people with diabetes in the U.K.
In March 2022, India Medtronic Private Ltd. announced the launch of the MiniMed 780G system in India. The MiniMed 780G system is a next generation closed loop insulin pump system for the treatment of type 1 diabetes in people age 7 to 80 years.
In March 2022, Novo Nordisk launched smart insulin pens in the U.K., giving people treated within the NHS (the National Health Institutes) for diabetes access to devices that can monitor and record dosing information for the first time.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
